Home > Boards > US OTC > Medical - Drugs >

Entest BioMedical Inc. (ENTB)

Add ENTB Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator gotinearly, ronrooster, sizzleweed, Kbro13
Search This Board:
Last Post: 7/7/2015 1:00:38 AM - Followers: 458 - Board type: Free - Posts Today: 1






Company Information:                                                      
4700 Spring Street, Suite 304
La Mesa, Calif. 91942
Telephone: 619-644-3344
Fax: 619-330-2328

Web site:


CIK 0001449447

ImenVax (TM)

Immuno-Therapeutic Cancer Treatment for Canines


In the encapsulated ImenVax™ device, a "cocktail" of integral immuno-catalysts are enclosed. From this ImenVax™ device immuno-catalysts are released which activate the patient's immune cell. These immune cells carry on their normal course of activity by entering the lymph nodes and cause T-Cell adaptation. These T-Cells are what attack and kill the tumor. (Figure 1)

Entest BioMedical Inc. (OTCQB: ENTB)is a majority owned subsidiary of Bio-Matrix Scientific Group Inc (OTCQB: BMSN). The Company is involved with the development of stem cell therapy treatments for Chronic Obstructive Pulmonary Disease (COPD), cancer immuno-therapies, testing procedures for diabetes and stem cell research applications for diabetes and other illnesses. The Company also is involved with medical device development (including stem cell extraction instrumentation).

Currently, Entest is focused on research and development in areas of COPD and Immuno-Therapeutic Cancer Vaccines. The Company sees applications for its patent pending technologies in both human and animal venues.

Immuno-therapeutic treatment of cancer - The patent pending Entest application involves perfecting the use of cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses in treating cancer. The treatment process itself will utilize an implantable encapsulation device as the vaccine delivery system and the initial focus will be treatment of cancer in canines. This canine cancer treatment may also provide clinical support for expansion into human cancer treatment.

Chronic Obstructive Pulmonary Disease -There is currently no cure for COPD and therapy is limited to management of the condition and its symptoms. Over the next 5 years, it is estimated that over $170 billion will be spent on treating COPD in the United States. Entest believes its COPD treatment, which utilizes patent pending adult stem cell therapy coupled with photoceutical device enhancement, has the potential to reverse COPD related lung damage as well as alleviate symptoms.

Entest BioMedical was founded for the purpose of providing excellence in biotechnology research (including adult stem cell regenerative treatment). Our objectives go beyond developing single products and procedures. Our mission is to discover and develop new procedures, treatments and medical devices that improve the quality of life. Our efforts revolve around a business focus of developing leading research and technology. Ongoing R&D is paramount to us in developing products and procedures with purpose, products and services that serve the present and help shape the future.



David R. Koos, PhD, DBA - Chairman and CEO, Secretary, Acting CFO
Feng Lin, MD, PhD - Director of Research
Marilyn Panahi - Director of Quality Assurance

 Recent News!

June 1, 2015




  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ENTB News: Current Report Filing (8-k) 06/26/2015 06:15:40 AM
ENTB News: Current Report Filing (8-k) 05/22/2015 09:13:17 AM
ENTB News: Quarterly Report (10-q) 04/10/2015 09:12:35 AM
ENTB News: Quarterly Report (10-q) 01/13/2015 06:03:03 AM
#36935  Sticky Note Today news COINSTRADERS 06/01/15 11:10:29 AM
#37131   some kind of big news will coinside with sizzleweed 07/07/15 01:00:38 AM
#37130   Funny! Hold your shares so shorty doesn't WIN!hehe Brakeman 07/06/15 04:18:10 PM
#37129   ENTB shareholders DO NOT sell at 1 or Crocs69 07/06/15 03:21:47 PM
#37128   Sec doesn't do anything in the penny stock Thrashing21 07/06/15 02:54:51 PM
#37127   We should all contact the SEC! Koos has Rk3 07/06/15 02:16:44 PM
#37126   Potentially yes. Holders of ENTB shares on bucks2pennies 07/06/15 02:09:48 PM
#37125   Thanks all! It's becoming clearer now. riskreward007 07/06/15 12:42:27 PM
#37124   They did this so that they have plenty LeGoose 07/06/15 12:39:28 PM
#37123   the A/S was reduced from 6Billion to 5oo Crocs69 07/06/15 12:32:36 PM
#37122   So are you saying that: riskreward007 07/06/15 12:23:41 PM
#37121   They reduced the total authorized shares from 6b ronrooster 07/06/15 12:20:22 PM
#37120   Right. riskreward007 07/06/15 12:20:05 PM
#37119   the 150 million shares owned by Dr Koos sizzleweed 07/06/15 12:17:36 PM
#37118   Previous Stock Value: Par Value Shares: 6,000,000,000 Value: sizzleweed 07/06/15 12:16:41 PM
#37117   Dividing 6 billion by 150: riskreward007 07/06/15 12:14:19 PM
#37116   The filing shows reduction of the A/S to 500k. riskreward007 07/06/15 12:10:45 PM
#37115   150/1 would put the count at 4 million sizzleweed 07/06/15 12:10:35 PM
#37114   And where is the link? Just copy and NoQuarter 07/06/15 12:08:57 PM
#37113   Honestly I am just as confused. The filing sizzleweed 07/06/15 12:07:49 PM
#37112   I'm confused. Can someone explain what is riskreward007 07/06/15 12:01:23 PM
#37111   Why would ppl be buying when we know Thrashing21 07/06/15 11:37:47 AM
#37110   The "scientists" 150m would reverse split the same ronrooster 07/06/15 11:26:36 AM
#37109   Load up them 2s hehe Brakeman 07/06/15 11:14:45 AM
#37108   Now that ENTB has released the r/s news,we ronrooster 07/06/15 10:58:37 AM
#37107   No, i'm trying to post realistic ones. As ADVFN_franknstein 07/06/15 10:14:28 AM
#37106   Can always count on you for positive and ctvette2003 07/06/15 09:52:53 AM
#37105   You won't be able to sell your shares ADVFN_franknstein 07/06/15 09:39:43 AM
#37104   So 150/1 split should put the price around .06? ctvette2003 07/06/15 09:29:47 AM
#37103   Item 5.03 Amendment of Articles of Incorporation LeGoose 07/06/15 09:20:29 AM
#37102   Great hearing it sounds good when their only Brakeman 07/06/15 07:50:02 AM
#37101   Sounds good, but why July 27? Is some sizzleweed 07/06/15 01:38:19 AM
#37100   Reasonable to consider 27Jul as a timeframe for Lewisinhk 07/05/15 06:44:51 PM
#37099   At least you will have almost $5 million Brakeman 07/05/15 09:41:51 AM
#37098   Great claims! instead of insults to Dr. Koos sizzleweed 07/04/15 05:34:52 PM
#37097   Koos NEEDS another DILUTIVE SHARE SELLING WELFARE ATM! SCAMDOOFUS angelicsatan666 07/04/15 08:47:14 AM
#37096   IMO This R/S will coinside with the Zander sizzleweed 07/04/15 02:44:58 AM
#37095   I just verified the information.check it out for yourself. ronrooster 07/03/15 10:36:58 PM
#37094   When I first got involved with ENTB it Brakeman 07/03/15 07:27:19 PM
#37093   My question is this, ctvette2003 07/03/15 06:32:53 PM
#37092   Somebody is a smart cookie. Shotime66 07/03/15 02:23:24 PM
#37091   Thanks jokers.Been holding for over a year now, stokjunky 07/03/15 11:50:49 AM
#37090   Stokjunky, there is not a statement, that will JokersWild12 07/03/15 11:20:53 AM
#37089   ENTB's a/s will go from current 6b to ronrooster 07/03/15 11:06:14 AM
#37088   It appears only insiders know that information about Brakeman 07/03/15 10:25:50 AM
#37087   I bet Siz is happy now since you Brakeman 07/03/15 07:32:49 AM
#37086   Where does it say anything about a 12 stokjunky 07/03/15 07:25:56 AM
#37085   Your Loss Is Our Gain. BlackDragons 07/03/15 12:17:44 AM
#37084   If this is the only update of our sante1 07/02/15 11:18:20 PM
#37083   1 for 12 is a very small rs prof81 07/02/15 09:08:17 PM
#37082   Looks to be a 1 for 12 split. JokersWild12 07/02/15 06:32:12 PM